Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil.

Gérardin P, Freitas ARR, Sissoko D.

Emerg Infect Dis. 2018 Sep;24(9):1773. doi: 10.3201/eid2409.180724. No abstract available.

2.

Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease.

Kerber R, Krumkamp R, Korva M, Rieger T, Wurr S, Duraffour S, Oestereich L, Gabriel M, Sissoko D, Anglaret X, Malvy D, May J, Županc TA, Muñoz-Fontela C, Günther S.

J Infect Dis. 2018 Aug 8. doi: 10.1093/infdis/jiy429. [Epub ahead of print]

PMID:
30101349
3.

Transmission dynamics and disease severity in children infected with East Central South African or ECSA-diverged clades of chikungunya virus.

Gérardin P, Freitas ARR, Sissoko D, Teixeira MG.

Clin Infect Dis. 2018 Jul 4. doi: 10.1093/cid/ciy534. [Epub ahead of print] No abstract available.

PMID:
29982440
4.

Individual and contextual risk factors for chikungunya virus infection: the SEROCHIK cross-sectional population-based study.

Fred A, Fianu A, Béral M, Guernier V, Sissoko D, Méchain M, Michault A, Boisson V, Gaüzère BA, Favier F, Malvy D, Gérardin P; SEROCHIK group.

Epidemiol Infect. 2018 Jun;146(8):1056-1064. doi: 10.1017/S0950268818000341. Epub 2018 May 3.

5.

[Integrating clinical research into epidemic response: the field perspective in the Ebola experience].

Malvy D, Sissoko D, Camara AM.

Med Sci (Paris). 2017 Oct;33(10):891-897. doi: 10.1051/medsci/20173310022. Epub 2017 Oct 10. Review. French.

6.

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.

Carroll MW, Haldenby S, Rickett NY, Pályi B, Garcia-Dorival I, Liu X, Barker G, Bore JA, Koundouno FR, Williamson ED, Laws TR, Kerber R, Sissoko D, Magyar N, Di Caro A, Biava M, Fletcher TE, Sprecher A, Ng LFP, Rénia L, Magassouba N, Günther S, Wölfel R, Stoecker K, Matthews DA, Hiscox JA.

mSphere. 2017 Aug 23;2(4). pii: e00325-17. doi: 10.1128/mSphereDirect.00325-17. eCollection 2017 Jul-Aug.

7.

Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.

Carazo Perez S, Folkesson E, Anglaret X, Beavogui AH, Berbain E, Camara AM, Depoortere E, Lefevre A, Maes P, Malme KN, Malvy JD, Ombelet S, Poelaert G, Sissoko D, Tounkara A, Trbovic P, Piguet P, Antierens A.

PLoS Negl Trop Dis. 2017 Jun 22;11(6):e0005545. doi: 10.1371/journal.pntd.0005545. eCollection 2017 Jun.

8.

How to treat Ebola virus infections? A lesson from the field.

Duraffour S, Malvy D, Sissoko D.

Curr Opin Virol. 2017 Jun;24:9-15. doi: 10.1016/j.coviro.2017.03.003. Epub 2017 Apr 11. Review.

9.

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.

Nguyen TH, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentré F; JIKI study group.

PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389. doi: 10.1371/journal.pntd.0005389. eCollection 2017 Feb.

10.

Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus.

Liu X, Speranza E, Muñoz-Fontela C, Haldenby S, Rickett NY, Garcia-Dorival I, Fang Y, Hall Y, Zekeng EG, Lüdtke A, Xia D, Kerber R, Krumkamp R, Duraffour S, Sissoko D, Kenny J, Rockliffe N, Williamson ED, Laws TR, N'Faly M, Matthews DA, Günther S, Cossins AR, Sprecher A, Connor JH, Carroll MW, Hiscox JA.

Genome Biol. 2017 Jan 19;18(1):4. doi: 10.1186/s13059-016-1137-3.

11.

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM, Colin G, Rieger T, Oestereich L, Pályi B, Wurr S, Guedj J, Nguyen THT, Eggo RM, Watson CH, Edmunds WJ, Bore JA, Koundouno FR, Cabeza-Cabrerizo M, Carter LL, Kafetzopoulou LE, Kuisma E, Michel J, Patrono LV, Rickett NY, Singethan K, Rudolf M, Lander A, Pallasch E, Bockholt S, Rodríguez E, Di Caro A, Wölfel R, Gabriel M, Gurry C, Formenty P, Keïta S, Malvy D, Carroll MW, Anglaret X, Günther S.

Lancet Glob Health. 2017 Jan;5(1):e80-e88. doi: 10.1016/S2214-109X(16)30243-1.

12.

Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child.

Sissoko D, Keïta M, Diallo B, Aliabadi N, Fitter DL, Dahl BA, Akoi Bore J, Raymond Koundouno F, Singethan K, Meisel S, Enkirch T, Mazzarelli A, Amburgey V, Faye O, Alpha Sall A, Magassouba N, Carroll MW, Anglaret X, Malvy D, Formenty P, Bruce Aylward R, Keïta S, Harouna Djingarey M, Loman NJ, Günther S, Duraffour S.

Clin Infect Dis. 2017 Feb 15;64(4):513-516. doi: 10.1093/cid/ciw793.

13.

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days.

Diallo B, Sissoko D, Loman NJ, Bah HA, Bah H, Worrell MC, Conde LS, Sacko R, Mesfin S, Loua A, Kalonda JK, Erondu NA, Dahl BA, Handrick S, Goodfellow I, Meredith LW, Cotten M, Jah U, Guetiya Wadoum RE, Rollin P, Magassouba N, Malvy D, Anglaret X, Carroll MW, Aylward RB, Djingarey MH, Diarra A, Formenty P, Keïta S, Günther S, Rambaut A, Duraffour S.

Clin Infect Dis. 2016 Nov 15;63(10):1353-1356. Epub 2016 Sep 1.

14.

[The register of activity at the Ebola treatment center in Forecariah (Guinea) from april 23 to june 5, 2015: analysis and thoughts].

Gaüzère BA, Ouellet I, Nottebrock D, Nied JC, Beya-Kadiebwe B, Camara AK, Camara D, Camara ML, Camara M, Soumah A, Tounkara MK, Monteil V, Camara A, Bauffe F, Camara A, Camara IB, Sissoko D, Simon B, Jaspard M, Tran-Minh T, L'Hériteau F.

Bull Soc Pathol Exot. 2016 Oct;109(4):272-280. Epub 2016 Jul 26. French.

PMID:
27459988
15.

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D; JIKI Study Group.

PLoS Med. 2016 Apr 5;13(4):e1002009. doi: 10.1371/journal.pmed.1002009. eCollection 2016 Apr.

16.

[Metastatic epiduritis in neurosurgery: Hospital data from the Abidjan teaching hospital, 2007-2012].

Jibia A, N'Dri OD, Sissoko D, Derou L, Broalet E, Varlet G, Ba Zeze V.

Med Sante Trop. 2016 Jan-Mar;26(1):57-63. doi: 10.1684/mst.2015.0522. French.

17.

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Réné Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D; JIKI Study Group.

PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. Erratum in: PLoS Med. 2016 Jun;13(6):e1002066. PLoS Med. 2016 Apr;13(4):e1002009. Dortenzio, Eric [corrected to D’Ortenzio, Eric].

18.

Drug assessment in the Ebola virus disease epidemic in west Africa.

Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JM, Dunning J, Sissoko D, Delfraissy JF, Levy Y.

Lancet Infect Dis. 2015 Nov;15(11):1258. doi: 10.1016/S1473-3099(15)00344-8. No abstract available.

19.

The influence of compositional and contextual factors on non-receipt of basic vaccines among children of 12-23-month old in India: a multilevel analysis.

Sissoko D, Trottier H, Malvy D, Johri M.

PLoS One. 2014 Sep 11;9(9):e106528. doi: 10.1371/journal.pone.0106528. eCollection 2014.

20.

[Investigation of urinary schistosomiasis outbreak in the primary school of the village Guébo 2, Abidjan, Côte d'Ivoire].

Soumahoro MK, Bosson-Vanga AH, Coulibaly KJ, Sidibé S, Angora E, Kouadio K, N'Douba AK, Sissoko D, Dosso M.

Bull Soc Pathol Exot. 2014 Aug;107(3):185-7. doi: 10.1007/s13149-014-0362-9. Epub 2014 May 16. French.

PMID:
24838686
21.

[Feedback from primary care practitioners two years after the chikungunya epidemic on Reunion Island, 2005-2006].

Fenétrier E, Sissoko D, Vernazza-Licht N, Bley D, Gaüzère BA, Malvy D.

Bull Soc Pathol Exot. 2013 Aug;106(3):193-200. doi: 10.1007/s13149-013-0295-8. Epub 2013 Jun 14. French.

PMID:
23765704
22.

[Malaria prevention: the general practitioners experience on the Reunion Island].

Di Bernardo S, Guihard B, Wartel G, Sissoko D.

Bull Soc Pathol Exot. 2012 Aug;105(3):245-9. doi: 10.1007/s13149-012-0238-9. Epub 2012 Jun 28. French.

PMID:
22744381
23.

[Malaria in France: Mainland and territories].

Tarantola A, Eltges F, Ardillon V, Lernout T, Sissoko D, Kendjo E, Achirafi A, Thiria J, Flamand C, D'Ortenzio E, Cohuet S, Quatresous I, Quenel P, Filleul L, Gastellu-Etchegorry M.

Med Mal Infect. 2011 Jun;41(6):301-6. doi: 10.1016/j.medmal.2011.02.004. Epub 2011 Apr 16. French.

PMID:
21498013
24.

Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte in 2008: the MAYDIA study.

Solet JL, Baroux N, Pochet M, Benoit-Cattin T, De Montera AM, Sissoko D, Favier F, Fagot-Campagna A.

Diabetes Metab. 2011 Jun;37(3):201-7. doi: 10.1016/j.diabet.2010.09.007. Epub 2010 Dec 28.

PMID:
21190885
25.

Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006.

Sissoko D, Ezzedine K, Giry C, Moendandzé A, Lernout T, D'Ortenzio E, Pettinelli F, Malvy D.

PLoS One. 2010 Nov 30;5(11):e14141. doi: 10.1371/journal.pone.0014141.

26.

[Migration, health and access to care in Mayotte Island in 2007: lessons learned from a representative survey].

Florence S, Lebas J, Parizot I, Sissoko D, Querre M, Paquet C, Lesieur S, Chauvin P.

Rev Epidemiol Sante Publique. 2010 Aug;58(4):237-44. doi: 10.1016/j.respe.2010.04.006. Epub 2010 Jul 14. French.

27.

Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006.

Sissoko D, Ezzedine K, Moendandzé A, Giry C, Renault P, Malvy D.

Trop Med Int Health. 2010 May;15(5):600-7. doi: 10.1111/j.1365-3156.2010.02485.x. Epub 2010 Mar 1.

28.

Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases.

Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur MC, Sissoko D, Ezzedine K, Malvy D.

J Clin Virol. 2010 Jan;47(1):85-8. doi: 10.1016/j.jcv.2009.11.014. Epub 2009 Dec 8.

PMID:
20004145
29.

Malaria imported into Réunion Island: is there a risk of re-emergence of the disease?

D'Ortenzio E, Sissoko D, Dehecq JS, Renault P, Filleul L.

Trans R Soc Trop Med Hyg. 2010 Apr;104(4):251-4. doi: 10.1016/j.trstmh.2009.10.008. Epub 2009 Nov 14.

PMID:
19914673
30.

Rift Valley fever, Mayotte, 2007-2008.

Sissoko D, Giry C, Gabrie P, Tarantola A, Pettinelli F, Collet L, D'Ortenzio E, Renault P, Pierre V.

Emerg Infect Dis. 2009 Apr;15(4):568-70. doi: 10.3201/eid1504.081045.

31.

Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V.

PLoS Negl Trop Dis. 2009;3(3):e389. doi: 10.1371/journal.pntd.0000389. Epub 2009 Mar 10.

32.

Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey.

Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet JL, Pierre V.

PLoS One. 2008 Aug 26;3(8):e3066. doi: 10.1371/journal.pone.0003066.

33.

[Outbreak of measles in Mayotte, Indian Ocean, 2005-2006].

D'Ortenzio E, Sissoko D, Landreau D, Benoit-Cattin T, Renault P, Pierre V.

Med Mal Infect. 2008 Nov;38(11):601-7. doi: 10.1016/j.medmal.2008.06.009. Epub 2008 Aug 22. French.

PMID:
18722725
34.

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion.

Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, Germonneau P, Quatresous I.

Epidemiol Infect. 2009 Apr;137(4):534-41. doi: 10.1017/S0950268808001167. Epub 2008 Aug 11.

PMID:
18694529
35.

High failure rate of first arterio-venous fistula in patients starting hemodialysis treatment: a report from the Ivory Coast.

Ackoundou-N'Guessan C, Gnionsahe A, Guei M, Sayegh M, Kossi S, Tia M, Sissoko DL.

Saudi J Kidney Dis Transpl. 2008 May;19(3):384-8.

36.

Outbreak of Chikungunya fever in Mayotte, Comoros archipelago, 2005-2006.

Sissoko D, Malvy D, Giry C, Delmas G, Paquet C, Gabrie P, Pettinelli F, Sanquer MA, Pierre V.

Trans R Soc Trop Med Hyg. 2008 Aug;102(8):780-6. doi: 10.1016/j.trstmh.2008.02.018. Epub 2008 Apr 8.

PMID:
18400240
37.

A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006.

Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, de Valk H, Ilef D, Ledrans M, Quatresous I, Quenel P, Pierre V.

Am J Trop Med Hyg. 2007 Oct;77(4):727-31.

PMID:
17978079
38.

[Malaria in Mayotte: epidemiology, diagnostic, prevention and treatment].

Receveur MC, Roussin C, Vatan R, de Montéra AM, Sissoko D, Malvy D.

Bull Soc Pathol Exot. 2004 Nov;97(4):265-7. French.

PMID:
17304748
39.

[Chikungunya epidemic on Reunion Island, 2005-2006].

Pierre V, Filleul L, Solet JL, Renault P, Sissoko D, Lassalle C.

Presse Med. 2006 Jul-Aug;35(7-8):1188-9; author reply 1189. French. No abstract available.

PMID:
16840898
40.

Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006.

Paquet C, Quatresous I, Solet JL, Sissoko D, Renault P, Pierre V, Cordel H, Lassalle C, Thiria J, Zeller H, Schuffnecker I.

Euro Surveill. 2006 Feb 2;11(2):E060202.3. No abstract available.

PMID:
16804203
41.

[Health status and issues on Reunion Island in 2005].

Catteau C, Sissoko D, Gauzere BA, Aubry P.

Med Trop (Mars). 2005 Nov;65(6):515-24. French. No abstract available.

PMID:
16555509
42.

Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.

Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, Boitte P, Cadoré B, Mouton Y.

HIV Med. 2006 Apr;7(3):140-5.

43.

[Mayotte: sanitary situation in an era of departmentalization].

Sissoko D, Receveur MC, Medinger G, Coulaud X, Polycarpe D.

Med Trop (Mars). 2003;63(6):553-8. French. No abstract available.

PMID:
15077413
44.
45.

A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naive to antiretrovirals.

De La Tribonniere X, Mouton Y, Vidal V, Darcissac E, Sissoko D, Fontier C, Douadi Y, Dewulf Jl, Amiel C, Bahr GM.

Med Sci Monit. 2003 Jun;9(6):PI43-50.

PMID:
12824957
46.

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.

Bahr GM, De La Tribonniere X, Darcissac E, Ajana F, Bocket L, Sissoko D, Yazdanpanah Y, Dewulf J, Amiel C, Mouton Y.

J Antimicrob Chemother. 2003 Jun;51(6):1377-88. Epub 2003 Apr 25.

PMID:
12716777
47.

[Availability of antiretroviral agents in the city: a 1-year assessment in the Lille metropolitan area].

de la Tribonnière X, de Grieck P, Baclet V, Dubreuil L, Alfandari S, Yazdanpanah Y, Sissoko D, Bourez JM, Valette M, Ajana F, Gérard Y, Senneville E, Mouton Y.

Sante Publique. 2001 Jun;13(2):151-60. French.

PMID:
11668805
48.

[Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].

Sissoko D, Ajana F, de la Tribonnière X, Baclet V, Mouton Y.

Presse Med. 2000 May 27-Jun 3;29(19):1041-2. French.

PMID:
10874910
49.

[Varicella-zoster virus meningo-encephalomyelitis without skin eruption].

Sissoko D, Bellagra N, Dewilde A, Rogelet P, Hober D, Wattré P.

Ann Biol Clin (Paris). 1998 Mar-Apr;56(2):211-2. French. No abstract available.

Supplemental Content

Loading ...
Support Center